Tactile Systems Technology Inc TCMD

$22.10 +0.39 (1.80%)

Valuation

Market cap
500,609,000
Revenue TTM
$329,520,000
Net income TTM
$19,090,000
PE ratio
20.10
Forward PE
19.83
Profit margin
5.79%
Debt to equity
0.00

Trading

Volume
252,300
Avg volume
316,566
Day's range
$21.61 – $22.43
Shares out
22,652,000
Stochastic %K
29%
Beta
0.82
Analysts
Strong Sell
Price target
$39.00

Price

Company profile

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home t...

Show more

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Industry
Medical Devices
Sector
Healthcare
Phone
612 355 5100
Website
https://tactilemedical.com
Address
3701 Wayzata Boulevard, Suite 300, Minneapolis, United States

Latest news

No headlines yet.